Escitalopram and Brimonidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Escitalopram (escitalopram oxalate) and Brimonidine (brimonidine). Common drug interactions include chronic kidney disease among females and dysphagia among males.

The phase IV clinical study analyzes what interactions people have when they take Escitalopram and Brimonidine. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Escitalopram?

Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 78,080 Escitalopram users. Check the latest studies of Escitalopram.

What is Brimonidine?

Brimonidine has active ingredients of brimonidine. It is often used in glaucoma. eHealthMe is studying from 6,276 Brimonidine users. Check the latest studies of Brimonidine.

On Jul, 11, 2026

40 people who take Escitalopram and Brimonidine together, and have interactions are studied.

Escitalopram and Brimonidine drug interactions.

What are the common drug interactions of Escitalopram and Brimonidine, by gender? *:

female:

Chronic kidney disease
Alopecia (absence of hair from areas of the body)
Inflammation
Sinusitis (inflammation of sinus)
Renal failure (kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Bone density decreased
Emotional distress
Osteoporosis (bones weak and more likely to break)
Pain

male:

Dysphagia (a condition in which swallowing is difficult or painful)
Confusional state
Vomiting
Acute myocardial infarction (acute heart attack)
Ataxia (loss of full control of bodily movements)
B-cell lymphoma (blood cancer affecting b cells)
Blindness unilateral
Blood glucose increased
Chronic kidney disease
Constipation

What are the common drug interactions of Escitalopram and Brimonidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)

30-39:

Diarrhoea

40-49:

n/a

50-59:

Alopecia (absence of hair from areas of the body)
Chronic kidney disease
Inflammation
Sinusitis (inflammation of sinus)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Bone density decreased
Emotional distress
Osteoporosis (bones weak and more likely to break)
Pain
Blood pressure fluctuation

60+:

Chronic kidney disease
Death
Gastroenteritis norovirus (inflammation of stomach and intestine caused by norovirus infection)
Acute myocardial infarction (acute heart attack)
Ataxia (loss of full control of bodily movements)
B-cell lymphoma (blood cancer affecting b cells)
Blindness unilateral
Confusional state
Constipation
Decreased appetite

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 25.00%
Pain: 8 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 17.50%
Stress And Anxiety: 6 people, 15.00%
High Blood Pressure: 5 people, 12.50%
Multiple Myeloma (cancer of the plasma cells): 5 people, 12.50%
High Blood Cholesterol: 4 people, 10.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 10.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 7.50%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 3 people, 7.50%

* Approximation only. Some reports may have incomplete information.

Do you take Escitalopram and Brimonidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously